Composition
- Active ingredients
- ALOGLIPTIN BENZOATE EQ 25MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA210213.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Alogliptin
- Active substance
- alogliptin benzoate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- MSN Labs PVT LTD
- Status
- Tentative approval
- FDA approval
- 29 Jan 2019
- Application
- ANDA210213-003